The same judge who previously overturned a $150 million AndroGel verdict has reversed a second verdict in the litigation worth over $140 million.
The case was brought by Tennessee resident Jeffrey Konrad. Konrad alleges that his two-month period of using AbbVie’s AndroGel testosterone replacement product caused him to have a heart attack in 2010. A Chicago jury agreed and awarded him $140,000 in compensatory damages and $140 million punitively in response ...
continue reading...When an AndroGel lawsuit brought against pharmaceutical manufacturer AbbVie resulted in a $150 million award for the Oregon resident who filed it, the legal world took notice. The award was unique not only for the amount, but also in the way the amount was distributed.
A Chicago jury awarded plaintiff Jesse Mitchell nothing in compensation for the injuries or medical costs he incurred after a heart attack he attributed ...
continue reading...An Arizona man was unsuccessful in his attempt to find AndroGel manufacturer AbbVie responsible for a pulmonary embolism he suffered two months after starting testosterone replacement therapy. The lawsuit, filed in 2014 and decided just recently, claimed that AbbVie misled the public by focusing most of its television advertising on off-label uses for the drug.
Testosterone therapy and replacement commercials have taken ...
continue reading...Yet again, a jury sent AbbVie, maker of the popular prescription testosterone drug Androgel, a loud and clear message. A federal jury in Chicago found that AbbVie misrepresented the dangers of using Androgel. And to make sure the drugmaker got their message, it also reached a verdict in excess of $140 million.
This most recent trial is the second bellwether case to be tried in the federal testosterone replacement ...
continue reading...
As we’ve seen with the opioid epidemic sweeping across the country, the more available a prescription drug becomes, the greater the potential seems to become for that prescription drug to be abused. As drug companies flood American cities and towns with more painkillers than they could possibly take under normally-prescribed conditions, the number of overdoses and deaths has skyrocketed.
Sadly, that same kind of dependency and abuse is now starting to show ...
continue reading...A recent Forbes article explores the prevalence of “Low-T” drug ads by companies like AbbVie and Eli Lilly & Co., and how two men’s health experts think the advertisements should be banned.
Testosterone therapy products have been associated with an increased risk of serious cardiovascular health effects. A study published in November 2013 linked testosterone therapy to increased rates of heart attack, stroke, and ...
continue reading...
